Seres Therapeutics Inc (MCRB) — Cash Flow Quality Index
Seres Therapeutics Inc (MCRB) has a Cash Flow Quality Index of 0.27x as of September 2025. Operating cash flow of $2.21 Million is below net income of $8.20 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore MCRB cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Seres Therapeutics Inc Cash Flow Quality Index (2024–2025)
Historical Cash Flow Quality Index for Seres Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Seres Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Seres Therapeutics Inc (2024–2025)
Year-by-year earnings quality comparison for Seres Therapeutics Inc. For live market cap and the full company financial profile, see MCRB market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | $1.12 Million | $5.70 Million | ▲ +100.0% |
| 2024 | -1092.71x | $-148.61 Million | $136.00K | — |